Canadian Halal Investor.

NYSE Shariah screener · October 2026

Is Thermo Fisher Scientific Inc. (TMO) Halal?

PASS

Thermo Fisher Scientific Inc. · NYSE: TMO · Healthcare

The short answer

Yes — Thermo Fisher Scientific Inc. (TMO) passes this Shariah stock screen. The Waltham-based life sciences tools and services company (Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, Laboratory Products and Biopharma Services — brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon and PPD) has no disclosed prohibited business lines and no defense segment. Its total debt of $39,384M is about 15.80% of its ~$249.3B market cap ($652.51, October 1, 2026), below the ~33% ceiling. Interest income of $993M is about 2.23% of FY2025 revenue ($44,556M), below the 5% non-compliant income ceiling — corroborated exactly by Zoya's published figures. Zoya rates TMO Shariah-compliant and Musaffa classifies it as halal (August 2026); no ShariaPortfolio rating was found — honestly reported as absent, not invented.

Gate 1 — Business activity: PASS

Thermo Fisher Scientific Inc. (NYSE: TMO), founded in 1956 and headquartered in Waltham, Massachusetts, provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services worldwide. Per its FY2025 reporting it manages four segments: Life Sciences Solutions ($10.37B — biosciences, genetic sciences, bioproduction), Analytical Instruments ($7.55B — mass spectrometry, chromatography, electron microscopy), Specialty Diagnostics ($4.68B — immunodiagnostics, transplant diagnostics, microbiology) and Laboratory Products and Biopharma Services ($23.98B — lab distribution plus outsourced pharma services/clinical research). Brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. FY2025 revenue: $44,556M; ~125,000 employees. Haram flags: none. No alcohol, pork, gambling, tobacco, adult entertainment, conventional insurance/finance, or weapons businesses. No defense segment. No interest-based lending — it is a tools/instruments manufacturer and services company. Gate 1 passes. Facts only.

Gate 2 — Debt and cash: PASS

Per Thermo Fisher's Q1 2026 10-Q liquidity table (Dec 31, 2025 vs Mar 28, 2026), total debt was $39,384M at December 31, 2025 — the CFO confirmed on the Q4 2025 call that the company "ended the year with … $39.4 billion of total debt" (leverage 3.5× gross / 2.6× net). Against a market cap of about $249.3B ($652.51, October 1, 2026), debt ÷ market cap is about 15.80% — below the ~33% ceiling. Cash and cash equivalents ($9,852M) plus short-term investments ($253M) total $10,105M, about 4.05% of market cap. Interest expense was $1,419M in FY2025 — reported for completeness, not a screen input. Gate 2 passes. Facts only.

Gate 3 — Non-compliant income: PASS

Thermo Fisher's FY2025 full-year consolidated statement of income (earnings release Exhibit 99.1) reports "Interest income" of $993M against revenues of $44,556M — about 2.23% of revenue, below the 5% non-compliant income ceiling. Zoya's published figures corroborate these exactly ($44,556,000,000 revenue; $993,000,000 interest income = 2.23% of the combined total). Net income attributable was $6,704M. Gate 3 passes. Facts only.

Key figures used

Frequently asked questions

What does Thermo Fisher Scientific do?

Thermo Fisher Scientific Inc. (NYSE: TMO), founded in 1956 and headquartered in Waltham, Massachusetts, provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services worldwide. Per its FY2025 reporting it manages four segments: Life Sciences Solutions ($10.37B — biosciences, genetic sciences, bioproduction), Analytical Instruments ($7.55B — mass spectrometry, chromatography, electron microscopy), Specialty Diagnostics ($4.68B — immunodiagnostics, transplant diagnostics, microbiology) and Laboratory Products and Biopharma Services ($23.98B — lab distribution plus outsourced pharma services/clinical research). Brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. FY2025 revenue was $44,556M; ~125,000 employees.

Why does Thermo Fisher Scientific pass this Shariah stock screen?

Thermo Fisher passes all three gates of this screen. Its business is life sciences tools, analytical instruments, diagnostics and lab services — with no prohibited lines (no alcohol, gambling, pork, conventional banking/insurance, tobacco, weapons or adult entertainment; no defense segment). Total debt of $39,384M is about 15.80% of its ~$249.3B market cap, below the ~33% ceiling. Interest income of $993M is about 2.23% of FY2025 revenue ($44,556M), below the 5% non-compliant income ceiling — corroborated exactly by Zoya's published figures. Musaffa classifies TMO as halal and Zoya rates it Shariah-compliant. This is a factual screen, not a religious ruling — consult a qualified scholar for personal rulings.

What is Thermo Fisher Scientific's interest-bearing debt ratio?

Per Thermo Fisher's Q1 2026 10-Q liquidity table (Dec 31, 2025 vs Mar 28, 2026), total debt was $39,384M at December 31, 2025 — the CFO confirmed on the Q4 2025 call that the company "ended the year with … $39.4 billion of total debt" (leverage 3.5× gross / 2.6× net). Against a market cap of about $249.3B ($652.51, October 1, 2026), debt ÷ market cap is about 15.80% — below the ~33% ceiling. Cash and cash equivalents ($9,852M) plus short-term investments ($253M) total $10,105M, about 4.05% of market cap. Interest expense was $1,419M in FY2025 — reported for completeness, not a screen input.

What is Thermo Fisher Scientific's non-compliant income ratio?

Thermo Fisher's FY2025 full-year consolidated statement of income (earnings release Exhibit 99.1) reports "Interest income" of $993M against revenues of $44,556M — about 2.23% of revenue, below the 5% non-compliant income ceiling. Zoya's published figures corroborate these exactly ($44,556,000,000 revenue; $993,000,000 interest income = 2.23% of the combined total). Net income attributable was $6,704M.

Do Zoya, Musaffa, or ShariaPortfolio cover Thermo Fisher Scientific?

Zoya covers TMO (zoya.finance/stocks/tmo): the canonical answer is TMO is "Shariah-compliant and therefore considered halal to invest in" (the "As of" date is blank and the usual auto-template caveat applies), and its published numbers corroborate the filing figures exactly. Musaffa covers TMO (musaffa.com/stock/TMO/): "As of August 2026, Thermo Fisher Scientific Inc TMO is classified as halal" under AAOIFI methodology. ShariaPortfolio: no TMO-specific public rating found in web search — honestly reported as absent, not invented. This page applies the screen directly from Thermo Fisher's own filings.

Sources

Screened 2026-10-01 from published company figures and market data. Figures change; this page is educational, not financial advice and not a religious ruling.

Screened with our two-gate Shariah screening methodology (business-activity gate, then AAOIFI-style financial ratios).